AEMM Biotech Capital Investment Acquisition of STS Medical Group S.a r.l.

Luxembourg, July 4th 2022

Dear valued customer,

As announced in our communication of last May 6^th, we are pleased to inform you that our CEO, Mr Augusto Orsini, has completed the acquisition of the majority of the shares of STS Medical Group from the former owner, Monitor Clipper Partners, on June 24, 2022.

Mr. Orsini executed the transaction through AEMM Biotech Capital Investment, a Luxembourg-based family office with a long-term investment perspective in the health care space, acquiring more than 90% of the controlling shares of STS Medical Group S.a r.l., thereby increasing its presence in the single use medical device business area.

About AEMM biotech capital investment

AEMM supports and invests in start-ups and small- to medium-sized medical companies with a long-term perspective. The firm particularly looks to invest in businesses that promote sustainability and transparency.

AEMM aims to grow STS Medical Group through consolidation of the European customized kits market and overseas expansion.

To achieve its ambitious goals for STS Medical Group and other investments, AEMM also understands the importance of effective wealth management strategies. As the company supports start-ups and medical companies, it recognizes that financial success goes hand-in-hand with prudent wealth planning solutions that are tailored to the unique needs of each client. AEMM collaborates with experienced wealth managers who can provide expert advice on wealth preservation, risk management, and asset allocation. By understanding the specific objectives and risk appetite of their clients, these wealth management professionals can craft customized investment plans that align with AEMM’s commitment to sustainability and transparency. Through a holistic approach to financial management, AEMM ensures that the companies they invest in and their clients have a solid foundation for long-term growth and prosperity.

About STS Medical Group

STS Medical Group achieved 2021 annual revenue of approximately €50mm in the European market through sales of medical devices under its “Secu” brand. STS medical Group is the recognized, highest-quality leader in customized kits (CPTs and small kits) both for surgical interventions and medical procedures in Europe. The company’s production facilities are located in Germany (Bavaria and Baden-Wurttemberg) and Bulgaria (Sandanski).

STS was founded in 2012 by Monitor Clipper Partners (a private equity firm based in Boston, MA) and Augusto Orsini a European entrepreneur with 30 years’ experience in the medical device business. Since it was established, STS has pursued a mission to provide efficient solutions to support the resource-constrained global health care system, thereby creating better and more cost effective outcomes.

We look forward to continuing this exciting journey with you to further strengthen STS while maintaining the high quality of our products, our reliable service and the highest level of transparency in the market.

Sincerely yours,

Augusto Orsini

For any query you might have regarding the executed transaction please contact us at the following email address:

info@stsmedicalgroup.com